We believe that emerging market (EM) equities are in the early stages of a multi-year recovery and are optimistic about continued EM outperformance vs. developed markets (DM) in 2018 and beyond. Looking to 2018, we are paying close attention to political continuity and economic stability in China, the start of a new global capital expenditure (capex) cycle, and attractive positioning and valuations for the EM equity asset class. READ MORE
Similar Posts:
- With China on ‘Extended’ Path to Reopening, Emerging Market Equities Will Outperform Peers in Developed Economies, Record Double-digit Growth, Allspring Analyst Says (SCMP)
- Outlook on Emerging Markets (Lazard AM)
- Are Emerging Markets Recoupling with Developed Markets? (II)
- Why Now Might be a Good Time for Risk-Tolerant Investors to Buy Into Emerging Markets (Globe and Mail)
- Emerging Markets vs Japan: Which Offers the Most Value? (Citywire)
- Which Emerging Markets May Benefit Most from the Rebound in China and the DM? (PGIM Fixed Income)
- Deciphering the Frontier Market Opportunity (Lazard)
- HSBC Gam’s Lievore Says Recent Sell-offs Are Reminders of Emerging Market Risk (FT Adviser)
- Frontier Markets: 2019 Outlook (FIS Group)
- Deutsche Bank: Emerging Market Rally is a False Dawn (Barron’s)
- South Africa Stocks “Expensive Within Emerging Markets” (Moneyweb.co.za)
- Investor Sentiment Survey: What Emerging Market Investors Think (Franklin Templeton)
- Emerging Market Resilience (Franklin Templeton Investments)
- Are Frontier Markets a Viable Alternative to Underperforming Emerging Markets? (PA)
- Emerging Markets Strategy Feb 2018: Volatility Returns, Fundamentals Stay Strong (JP Morgan)
